| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
June 21, 2017
Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.
-
June 12, 2017
Organization also premieres a suite of new products designed to improve operational efficiency and drive clinical excellence. NYON, Switzerland—(June 12, 2017) — Today at the 22nd IFCC-EFLM...
-
April 20, 2017
Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis BREA, Calif. — (April 20, 2017) — Beckman Coulter Diagnostics announced a...
March 7, 2017Beckman Coulter Diagnostics announces FDA clearance and U.S. commercial launch of its new DxC 700 AU chemistry analyzer. The new system brings together the advanced capabilities of two successful...
-
December 16, 2016
DETROIT, Mich — (Dec. 16, 2016) — Henry Ford Health System Pathology and Laboratory Medicine today announced a partnership with Beckman Coulter Inc. that enhances and streamlines operations by...
